Barely Significant
← all excerpts

Immunotherapy for microsatellite-stable colorectal cancer: overcoming resistance and exploring novel therapeutic strategies.

Ann Coloproctol · 2026 · PMC12971173 · PMID 41802306

Europe PMCDOI
1
hedged sentence
0.0380
closest p · 0.8× alpha
0.0380
boldest claim

The sentences

showed a trendP=0.038actually significant
1.7%) and showed a trend toward improved median OS (9.8 months vs. 9.3 months; HR, 0.83; 95% CI, 0.68–1.02; P=0.038).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.